Relief Therapeutics Holding AG (RLFTF)

[Clarnold]

thesisthink. Sure.

My estimate that we get a bump soon in the $1-2 dollar range is based on a DMC halt of the study and approval by the FDA for IV use of RLF-100. Directly following that would be a PR announcement (stated by Javitt) regarding the partnership to distribute the newly approved RLF-100. We are also supposed to start a trial of the inhaled version of RLF-100, but that probably wont' move the stock price much because we already know its happening. That would represent a 3-400% run up from our current price.

The study completion date for the inhaled version is Nov. 30th estimate. So assuming that goes well I think it could double+ the stock price from $2 up to $4-5. Next year.

Also, regarding the Trump effect. If he announces in October that RLF is the best thing in the world and the FDA starts touting it as whats going to save the world, then we could see $18 (seeking alphas suggested price), but more than likely would be bought out prior to that.

Is that better?